D. Belowski

发表

Extralipid effects of micronized fenofibrate in dyslipidemic patients.

M. Haberka, K. Labuzek, B. Okopień, 2006, Pharmacological reports : PR.

Antitumor activity of bestatin and thiorphan in mice.

A. Madej, D. Belowski, Z. Herman, 1995, Archivum immunologiae et therapiae experimentalis.

Hypolipidemic Drugs Affect Monocyte IL-1β Gene Expression and Release in Patients with IIa and IIb Dyslipidemia

B. Okopień, A. Madej, D. Belowski, 2005, Journal of cardiovascular pharmacology.

Recent insights into body weight control: From physiology to pathology

B. Okopień, A. Madej, D. Belowski, 2001, Journal of peptide science : an official publication of the European Peptide Society.

The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia.

K. Labuzek, B. Okopień, A. Madej, 2004, Atherosclerosis.

[Right atrial tumour and right ventricular failure - diagnostic role of echocardiography and cardiovascular magnetic resonance].

B. Okopień, A. Madej, D. Belowski, 2010, Kardiologia polska.

Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome.

B. Okopień, D. Belowski, J. Wysocki, 2004, International journal of clinical pharmacology and therapeutics.

Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia.

B. Okopień, A. Madej, D. Belowski, 2003, International journal of clinical pharmacology and therapeutics.

The new diagnostic approache in atherosclerosis management

D. Tokarz, B. Okopień, A. Madej, 2001 .

Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia.

B. Okopień, A. Madej, D. Belowski, 2004, Polish journal of pharmacology.

In-vitro Immunomodulatory Effects of Haloperidol and Perazine in Schizophrenia

A. Madej, D. Belowski, Z. Herman, 2000, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Influence of Neuroleptics on Cytotoxic Activity of Rat Natural Killer Cells

A. Madej, D. Belowski, Z. Herman, 1998 .

Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia

B. Okopień, A. Madej, D. Belowski, 2003, European Journal of Clinical Pharmacology.

[Current pharmacotherapy of obesity].

B. Okopień, A. Madej, D. Belowski, 2000, Polskie Archiwum Medycyny Wewnetrznej.

Monocyte Release of Tumor Necrosis Factor-α and Interleukin-1β in Primary Type IIa and IIb Dyslipidemic Patients Treated With Statins or Fibrates

Robert Krysiak, Andrzej Madej, B. Okopień, 2005, Journal of cardiovascular pharmacology.

Superoxide dismutase 1 and glutathione peroxidase 1 are involved in the protective effect of sulodexide on vascular endothelial cells exposed to oxygen-glucose deprivation.

B. Gabryel, J. Adamczyk, D. Belowski, 2016, Microvascular research.

The concept of unstable atherosclerotic plaque and pharmacological therapeutic strategies

B. Gabryel, D. Belowski, Krzysztof Łabuzek, 2016 .

Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner

B. Okopień, D. Belowski, M. Basiak, 2016, Pharmacological reports : PR.

Influence of antidepressant drugs on macrophage cytotoxic activity in rats.

A. Madej, D. Belowski, Z. Herman, 2004, Polish journal of pharmacology.

A new immunological marker of atherosclerotic injury of arterial wall.

D. Tokarz, B. Okopień, A. Madej, 2001, Research communications in molecular pathology and pharmacology.

Augmenting effect of methionine-enkephalin on interleukin-6 production by cytokine-stimulated murine macrophages

D. Belowski, Z. Herman, J. Kowalski, 2000, Neuropeptides.